195 related articles for article (PubMed ID: 12135483)
1. Differential regulation of telomerase activity by six telomerase subunits.
Chang JT; Chen YL; Yang HT; Chen CY; Cheng AJ
Eur J Biochem; 2002 Jul; 269(14):3442-50. PubMed ID: 12135483
[TBL] [Abstract][Full Text] [Related]
2. Function of HSP90 and p23 in the telomerase complex of thyroid tumors.
Boltze C; Schneider-Stock R; Roessner A; Quednow C; Hoang-Vu C
Pathol Res Pract; 2003; 199(9):573-9. PubMed ID: 14621192
[TBL] [Abstract][Full Text] [Related]
3. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
Boltze C; Lehnert H; Schneider-Stock R; Peters B; Hoang-Vu C; Roessner A
Endocrine; 2003 Dec; 22(3):193-201. PubMed ID: 14709792
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
Akalin A; Elmore LW; Forsythe HL; Amaker BA; McCollum ED; Nelson PS; Ware JL; Holt SE
Cancer Res; 2001 Jun; 61(12):4791-6. PubMed ID: 11406554
[TBL] [Abstract][Full Text] [Related]
5. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT.
Lee JH; Chung IK
Cancer Lett; 2010 Apr; 290(1):76-86. PubMed ID: 19751963
[TBL] [Abstract][Full Text] [Related]
7. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.
Kyo S; Kanaya T; Takakura M; Tanaka M; Inoue M
Int J Cancer; 1999 Jan; 80(1):60-3. PubMed ID: 9935231
[TBL] [Abstract][Full Text] [Related]
8. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells.
Yamada K; Yajima T; Yagihashi A; Kobayashi D; Koyanagi Y; Asanuma K; Yamada M; Moriai R; Kameshima H; Watanabe N
Jpn J Cancer Res; 2000 Dec; 91(12):1278-84. PubMed ID: 11123427
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma.
Boltze C; Mundschenk J; Unger N; Schneider-Stock R; Peters B; Mawrin C; Hoang-Vu C; Roessner A; Lehnert H
J Clin Endocrinol Metab; 2003 Sep; 88(9):4280-6. PubMed ID: 12970299
[TBL] [Abstract][Full Text] [Related]
10. Stable association of hsp90 and p23, but Not hsp70, with active human telomerase.
Forsythe HL; Jarvis JL; Turner JW; Elmore LW; Holt SE
J Biol Chem; 2001 May; 276(19):15571-4. PubMed ID: 11274138
[TBL] [Abstract][Full Text] [Related]
11. Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR.
Banik SS; Counter CM
J Biol Chem; 2004 Dec; 279(50):51745-8. PubMed ID: 15381700
[TBL] [Abstract][Full Text] [Related]
12. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.
Ito H; Kyo S; Kanaya T; Takakura M; Inoue M; Namiki M
Clin Cancer Res; 1998 Jul; 4(7):1603-8. PubMed ID: 9676833
[TBL] [Abstract][Full Text] [Related]
13. Specificity and stoichiometry of subunit interactions in the human telomerase holoenzyme assembled in vivo.
Egan ED; Collins K
Mol Cell Biol; 2010 Jun; 30(11):2775-86. PubMed ID: 20351177
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.
Counter CM; Meyerson M; Eaton EN; Ellisen LW; Caddle SD; Haber DA; Weinberg RA
Oncogene; 1998 Mar; 16(9):1217-22. PubMed ID: 9528864
[TBL] [Abstract][Full Text] [Related]
15. Hsp90-binding immunophilin FKBP52 modulates telomerase activity by promoting the cytoplasmic retrotransport of hTERT.
Jeong YY; Her J; Oh SY; Chung IK
Biochem J; 2016 Oct; 473(20):3517-3532. PubMed ID: 27503910
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
17. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
Kyo S; Kanaya T; Takakura M; Tanaka M; Yamashita A; Inoue H; Inoue M
Int J Cancer; 1999 Mar; 80(6):804-9. PubMed ID: 10074910
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
[TBL] [Abstract][Full Text] [Related]
19. hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
Campbell LJ; Fidler C; Eagleton H; Peniket A; Kusec R; Gal S; Littlewood TJ; Wainscoat JS; Boultwood J
Leukemia; 2006 Apr; 20(4):671-9. PubMed ID: 16498395
[TBL] [Abstract][Full Text] [Related]
20. E2F-1 represses transcription of the human telomerase reverse transcriptase gene.
Crowe DL; Nguyen DC; Tsang KJ; Kyo S
Nucleic Acids Res; 2001 Jul; 29(13):2789-94. PubMed ID: 11433024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
